Prostate Cancer Clinical Trial

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Summary

The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of metastatic prostatic adenocarcinoma
Receiving luteinizing hormone-releasing hormone (LHRH) agonist or LHRH antagonist therapy continuously for at least 1 year with anticipated lifelong therapy
Able to complete written surveys in English

Exclusion Criteria:

More than 2 prior systemic treatment regimens utilized in addition to castration.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

100

Study ID:

NCT04705038

Recruitment Status:

Recruiting

Sponsor:

University of Chicago

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Chicago Medicine Comprehensive Cancer Center
Chicago Illinois, 60637, United States More Info
Clinical Trials Intake
Contact
855-702-8222
[email protected]
Walter Stadler, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

100

Study ID:

NCT04705038

Recruitment Status:

Recruiting

Sponsor:


University of Chicago

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.